Dennis Huang
Net worth: 4 M $ as of 2026-08-30
Net worth: 4 M $ as of 2026-08-30
Presently, Dennis Karl Huang holds the position of Chief Technical Operations Officer & Senior VP at Ultragenyx Pharmaceutical, Inc. Mr. Huang is also on the board of Bonti, Inc. In the past he occupied the position of VP-Biologics Manufacturing & Development at Allergan, Inc. and Senior VP-Manufacturing & Supply Chain at InterMune, Inc. Mr. Huang received an undergraduate degree from Knox College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-15 | 147,845 ( 0.15% ) | 4 M $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 2015-04-30 |
Bonti, Inc.
Bonti, Inc. Pharmaceuticals: MajorHealth Technology Develops novel treatments | Director/Board Member | - |
CytoDel LLC
CytoDel LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company which produces recombinant derivatives of botulinum neurotoxin | Director/Board Member | - |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Director/Board Member | 2023-04-27 |
Ornovi, Inc.
Ornovi, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a pre-clinical stage therapeutics company | Director/Board Member | 2020-12-31 |
| Companies | Position | End |
|---|---|---|
| INTERMUNE INC | Corporate Officer/Principal | 2015-02-28 |
| ALLERGAN, INC. | Corporate Officer/Principal | 2013-07-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
InterMune, Inc.
InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Knox College
Knox College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Bonti, Inc.
Bonti, Inc. Pharmaceuticals: MajorHealth Technology Develops novel treatments | Health Technology |
CytoDel LLC
CytoDel LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company which produces recombinant derivatives of botulinum neurotoxin | Health Technology |
Ornovi, Inc.
Ornovi, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a pre-clinical stage therapeutics company | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions